Re-administration after the failure of gefitinib or erlotinib in patients with advanced non-small cell lung cancer.
about
The Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell LinesPredictive Factors for Switched EGFR-TKI Retreatment in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.Predictive factors associated with gefitinib response in patients with advanced non-small-cell lung cancer (NSCLC).Advanced lung adenocarcinoma with spinal cord metastasis successfully treated with second EGFR-TKI treatment: a case report and literature review.Treatment and prognosis after progression in long-term responders to EGFR-tyrosine kinase inhibitor in advanced non-small cell lung cancerStudy of efficacy and safety of pulsatile administration of high-dose gefitinib or erlotinib for advanced non-small cell lung cancer patients with secondary drug resistance: A single center, single arm, phase II clinical trial.Tyrosine kinase inhibitors re-treatment beyond progression: choice and challenge.Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review.Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study.
P2860
Q28547067-C0705E3E-D2AB-4CA6-BEA5-6D5FBB517505Q33567383-9AD3660F-6774-4AC8-9F0A-82E87D97B94AQ34130163-EC159DDE-9A44-472D-871E-A67F087A31DDQ36140022-8DEB0904-46BE-4124-B4E6-663776FF9F08Q36582368-D056670B-1595-424A-89A7-6B7A1DE1DEFDQ37389611-63D5543B-5E7F-4D8D-BA53-C429AE940D99Q38224482-9C78A2DE-C278-4160-9918-299A6F18D602Q38390205-2F51BF1F-4F85-4046-A732-9E557775E54FQ42673264-17C0078E-CD45-4E28-B267-9D83AC00B0E8
P2860
Re-administration after the failure of gefitinib or erlotinib in patients with advanced non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Re-administration after the fa ...... ed non-small cell lung cancer.
@en
Re-administration after the fa ...... ed non-small cell lung cancer.
@nl
type
label
Re-administration after the fa ...... ed non-small cell lung cancer.
@en
Re-administration after the fa ...... ed non-small cell lung cancer.
@nl
prefLabel
Re-administration after the fa ...... ed non-small cell lung cancer.
@en
Re-administration after the fa ...... ed non-small cell lung cancer.
@nl
P2093
P2860
P1476
Re-administration after the fa ...... ed non-small cell lung cancer.
@en
P2093
Beibei Zhang
Chunxiao He
Yiping Zhang
Zhengbo Song
P2860
P304
P356
10.3978/J.ISSN.2072-1439.2013.07.28
P577
2013-08-01T00:00:00Z